BlinkBio Competitors and Similar CompaniesClear all

BlinkBio's competitors and similar companies include Karo Healthcare, Xilio Therapeutics and BioAtla.
BlinkBio
BlinkBio
BlinkBio is a company developing tunable drug conjugates (TDCs) therapies.
Karo Healthcare
Karo Healthcare
Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
Xilio Therapeutics
Xilio Therapeutics
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
BioAtla
BioAtla
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
Founding Date
Founding Date
2009
Founding Date
1987
Founding Date
2015
Founding Date
2007
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Jupiter, US HQ
Locations
Stockholm, SE HQ
Stockholm, SE
Locations
Waltham, US HQ
Locations
San Diego, US HQ
Employees
Employees
5
Employees
225
Employees
69
Employees
616% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
43.5 m
Valuation ($)
100.8 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
kr3b (FY, 2021)
Revenue (est.)
$43.8m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
(kr17m) (FY, 2021)
Net income
($35m) (FY, 2025)
Net income
($59.6m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 233m
Total funding raised
$ 186.5m
For sources of this data, please see the company profile

View Company Profiles

Karo Healthcare
HQ
Stockholm, SE

Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.

View company
Xilio Therapeutics
HQ
Waltham, US
Employees
69

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.

View company
BioAtla
HQ
San Diego, US
Employees
61↓ 6% decrease

BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.

View company